World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
about
Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300Mechanisms of vancomycin resistance in Staphylococcus aureusTreatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesisFusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureusTwo percent sodium chloride is required for susceptibility testing of staphylococci with oxacillin when using agar-based dilution methodsAntimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province, South AfricaFosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.Nasal carriage of methicillin resistant staphylococci in healthy population of East sikkimIn vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis.Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital.Identification of aminoglycoside-modifying enzymes by susceptibility testing: epidemiology of methicillin-resistant Staphylococcus aureus in Japan.Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureusActivities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groupsVancomycin sensitivity of Staphylococcus aureus isolates from hospital patients in Karachi, Pakistan.Staphylococcus aureus susceptibility to innate antimicrobial peptides, beta-defensins and CAP18, expressed by human keratinocytesCritical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus.In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganismsImportance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureusIn vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms.Detection of methicillin resistance in staphylococci by using a DNA probeCiprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital.Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureusDetection of methicillin and mupirocin resistance in Staphylococcus aureus isolates using conventional and molecular methods: a descriptive study from a burns unit with high prevalence of MRSA.In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organismsIn vitro antistaphylococcal activities of two investigative fluoroquinolones, CI-960 and WIN 57273, compared with those of ciprofloxacin, mupirocin (pseudomonic acid), and peptide-class antimicrobial agents.Graphene oxide-silver nanocomposite as a promising biocidal agent against methicillin-resistant Staphylococcus aureus.Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.Analysis of methicillin-resistant and methicillin-susceptible Staphylococcus aureus by a molecular typing method based on coagulase gene polymorphisms.Vancomycin Ophthalmic Ointment 1% for methicillin-resistant Staphylococcus aureus or methicillin-resistant Staphylococcus epidermidis infections: a case series.Resistance to vancomycin and teicoplanin: an emerging clinical problem.In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococciEmergence of quinolone resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Ontario, CanadaVancomycin for treatment of invasive, multi-drug resistant Staphylococcus aureus infections.Methicillin-resistant Staphylococcus aureus--an overview.Distribution of tsst-1 and mecA Genes in Staphylococcus aureus Isolated From Clinical SpecimensHyaluronidase expression and biofilm involvement in Staphylococcus aureus UAMS-1 and its sarA, agr and sarA agr regulatory mutantsGenomic analysis of an emerging multiresistant Staphylococcus aureus strain rapidly spreading in cystic fibrosis patients revealed the presence of an antibiotic inducible bacteriophage.Comparison of traditional and molecular methods of typing isolates of Staphylococcus aureus.
P2860
Q24611360-EA1D2C22-13F9-4729-BEDB-A9543E08332AQ26829312-C0FFBD88-9D98-4999-83A5-2627B8798A01Q28368185-49269E72-73DD-4E7D-BF35-14FEE4334559Q28378451-3686DB94-20EF-4EA2-925F-4C13778B51F9Q30451517-6B63F9C4-8F4A-46B4-A509-A16E91E99729Q33252160-A6F7626F-4DF7-428D-BE8F-96F833705D74Q33472890-38D7D7BC-C276-4186-A44F-AE0CEEF875FBQ33654256-6FCED031-E75B-4877-8091-A75600CF8B78Q33750394-494001BC-2B01-45FE-B098-64FDBDF35C8EQ33755710-2FDFC374-AEA4-4813-8BBD-CFEBA2606974Q33973328-8A20B73F-C0CE-454E-8FEB-0E0F2A93A685Q33979371-09C9BDD2-3C00-4126-AE28-00D3BC8A93C4Q33981950-9D0D5A44-0EA0-49F3-A73B-1EB609A1A872Q34044328-C1ADD384-4F49-4F03-8C2C-F5A797FD8A8CQ34803935-F98DBB2D-70B6-4F2E-B814-8550A2395781Q35106151-0FD5D399-3F73-438A-BE4F-E6AC233973A0Q35111627-7B7EBCAE-946B-4EC2-AD2E-F2C12B38B383Q35120346-9CD0D9FE-9568-42B7-8B54-69616854AA5CQ35124432-197032A0-A962-43F6-A086-BE8213167808Q35124610-1FF656EF-76B0-4DEF-A060-17F5F254EAD8Q35126947-5B277BA5-F652-42FE-9AD1-A65E7673955CQ35272510-67BD396F-A3E7-41C9-9E88-B122636047FDQ35279768-6236AF8A-2320-4497-91C1-460B99094196Q35284471-BDC5791A-1C34-445B-8B38-C50636581799Q35586410-E148AED0-D13C-46C5-8CBC-35EA7B6B9DAFQ35810723-2B2E6343-06B9-493E-A4C8-BFE7490F7808Q35846160-39180390-E498-4F3B-AB97-7A81E54F0A24Q36257260-3802494E-8C4E-4087-B4A6-E38DAF08CF7DQ36409465-88D9B8A6-B4AB-4F5A-87C7-2E072701CF1BQ36504403-7889BFDE-E1B2-414F-98D1-CCF89DBBA1D3Q36584136-017A82CC-7AF2-4F38-A8CE-58068E58166DQ36636341-894001D0-A114-47D8-B767-917D1C340FAFQ36753160-5D3BE13B-7754-4E4E-9A43-69F36FAEA81EQ36754974-E0E9B476-1753-4F37-A4FF-8604D871529EQ36847287-584BCA96-B793-4849-9C89-4E5D9BE7A005Q36911203-025D235E-53D6-4AEF-BE3D-440A46AF5838Q36925995-27D143DE-091B-4C47-8A17-5A1DDCFF82ECQ37007474-665FA709-30F3-418E-96EB-BDCABAD9AA55Q37069059-37A37265-828D-4686-88C0-15DB3E797153Q37071567-708622AA-331A-4CCA-8368-2865D310E0D3
P2860
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@en
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@nl
type
label
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@en
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@nl
prefLabel
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@en
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@nl
P2093
P1433
P1476
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
@en
P2093
J M Hamilton-Miller
W Brumfitt
P304
P356
10.1016/S0140-6736(89)90076-7
P407
P577
1989-03-01T00:00:00Z